Invictus RG’s Kindred Healthcare KND Stock Holding History

Invictus RG’s Portfolio KND Stock Details KND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-20,749	Closed	-$173K	–	925
2017 Q1	$173K	Buy	+20,749	New	+$162K	0.12%	349

Other funds holding KND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Invictus RG's KND Position: Q2 2017 in Review

Invictus RG sold out of Kindred Healthcare (KND) in Q2 2017, closing a stake of 20,749 shares — an estimated $173K sold.

Invictus RG first reported a position in KND in Q1 2017 and held it in 1 quarter. The position peaked at $173K in Q1 2017. 179 funds tracked by Wall St. Rank hold KND as of Q2 2017.

Invictus RG reported no remaining Kindred Healthcare position as of Q2 2017 after selling out during the quarter.
Invictus RG sold 20,749 Kindred Healthcare shares in Q2 2017, an estimated $173K.
Invictus RG first reported a position in Kindred Healthcare in Q1 2017 and held it in 1 quarter.
Invictus RG's Kindred Healthcare position peaked at $173K in Q1 2017.
179 funds tracked by Wall St. Rank held Kindred Healthcare as of Q2 2017.

Based on Invictus RG's 13F filing for Q2 2017, filed 14 Aug 2017.